Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00432510
Status:
COMPLETED
Last Update Posted:
2021-06-03
First Post:
2007-02-07
Brief Title:
Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects
Sponsor:
Shire
Organization:
Takeda
Study Overview
Official Title:
Protocol LEVP2006-5 Pharmacokinetics of C1INH-nf in Hereditary Angioedema Subjects
Status:
COMPLETED
Status Verified Date:
2021-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study objective was to describe the pharmacokinetics PK of one or two doses of C1 esterase inhibitor C1INH-nf in hereditary angioedema HAE subjects who were not experiencing an HAE attack
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None